CME Group Inc. (NASDAQ:CME) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 6,959,808 shares, an increase of 37.7% from the October 31st total of 5,052,862 shares. Based on an average trading volume of 2,603,900 shares, the days-to-cover ratio is presently 2.7 days. Approximately 2.2% of the company’s shares are sold short.

In other CME Group news, Director Dennis Suskind sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 2nd. The stock was sold at an average price of $100.52, for a total value of $201,040.00. Following the completion of the sale, the director now directly owns 8,499 shares in the company, valued at approximately $854,319.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Kimberly S. Taylor sold 2,300 shares of the company’s stock in a transaction on Tuesday, August 30th. The stock was sold at an average price of $107.16, for a total value of $246,468.00. Following the completion of the sale, the insider now owns 101,489 shares of the company’s stock, valued at $10,875,561.24. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in CME Group by 2.1% in the second quarter. Vanguard Group Inc. now owns 20,131,757 shares of the company’s stock worth $1,960,833,000 after buying an additional 406,686 shares during the period. Capital International Investors raised its position in CME Group by 1.8% in the second quarter. Capital International Investors now owns 11,079,915 shares of the company’s stock worth $1,079,184,000 after buying an additional 197,881 shares during the period. BlackRock Institutional Trust Company N.A. raised its position in CME Group by 0.3% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 10,124,205 shares of the company’s stock worth $1,058,182,000 after buying an additional 31,832 shares during the period. BlackRock Fund Advisors raised its position in CME Group by 4.3% in the third quarter. BlackRock Fund Advisors now owns 9,464,800 shares of the company’s stock worth $989,261,000 after buying an additional 391,783 shares during the period. Finally, JPMorgan Chase & Co. raised its position in CME Group by 1.3% in the third quarter. JPMorgan Chase & Co. now owns 7,064,945 shares of the company’s stock worth $738,427,000 after buying an additional 88,456 shares during the period. Hedge funds and other institutional investors own 79.09% of the company’s stock.

Several equities research analysts have weighed in on the company. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $116.00 target price for the company in a report on Thursday, August 4th. RBC Capital Markets set a $92.00 target price on CME Group and gave the stock a “sell” rating in a report on Friday, October 28th. Jefferies Group upped their target price on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. Royal Bank Of Canada decreased their price objective on CME Group from $97.00 to $92.00 and set an “underperform” rating for the company in a research note on Friday, October 28th. Finally, JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the stock a “buy” rating in a research note on Monday, September 12th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. CME Group presently has an average rating of “Hold” and a consensus price target of $102.89.

CME Group (NASDAQ:CME) opened at 112.84 on Friday. The stock has a 50 day moving average price of $106.96 and a 200-day moving average price of $102.74. The firm has a market capitalization of $38.29 billion, a price-to-earnings ratio of 26.30 and a beta of 0.81. CME Group has a one year low of $81.87 and a one year high of $117.80.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 27th. The company reported $1.05 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.04 by $0.01. The firm earned $842 million during the quarter, compared to analyst estimates of $855.94 million. CME Group had a return on equity of 6.90% and a net margin of 41.54%. CME Group’s revenue was down 1.0% compared to the same quarter last year. During the same period last year, the business posted $1.02 earnings per share. On average, analysts predict that CME Group will post $4.35 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 28th. Investors of record on Friday, December 9th will be issued a $0.60 dividend. The ex-dividend date is Wednesday, December 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.13%. CME Group’s dividend payout ratio (DPR) is presently 55.94%.

TRADEMARK VIOLATION WARNING: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/27/cme-group-inc-cme-short-interest-up-37-7-in-november.html.

About CME Group

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.